Abilify and Vaniqa drug interactions - a phase IV clinical study of FDA data
Drug interactions are reported among 2 people who take Abilify and Vaniqa. Common interactions include anxiety among females.
The phase IV clinical study analyzes what interactions people who take Abilify and Vaniqa have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
2 people who take Abilify and Vaniqa together, and have interactions are studied.
What is Abilify?
Abilify has active ingredients of aripiprazole. It is used in depression. Currently, eHealthMe is studying from 98,604 Abilify users.
What is Vaniqa?
Vaniqa has active ingredients of eflornithine hydrochloride. Currently, eHealthMe is studying from 630 Vaniqa users.
Number of Abilify and Vaniqa reports submitted per year:
Common Abilify and Vaniqa drug interactions by gender *:
- Carpal tunnel syndrome
- Suicidal ideation
* Approximation only. Some reports may have incomplete information.
Do you take Abilify and Vaniqa?Personalize this study to your gender and age
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
- Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .
Drug side effects by duration, gender and age:
Common Abilify drug interactions:
- Abilify and Seroquel: 7,633 reports
- Abilify and Risperdal: 5,828 reports
- Abilify and Cymbalta: 5,352 reports
- Abilify and Zyprexa: 5,157 reports
- Abilify and Wellbutrin: 4,949 reports
- Abilify and Lamictal: 4,705 reports
- Abilify and Lexapro: 3,790 reports
- Abilify and Clonazepam: 3,741 reports
- Abilify and Zoloft: 3,672 reports
- Abilify and Depakote: 3,438 reports
Browse interactions between Abilify and drugs from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
Browse interactions between Vaniqa and drugs from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
How the study uses the data?
The study uses data from the FDA. It is based on aripiprazole and eflornithine hydrochloride (the active ingredients of Abilify and Vaniqa, respectively), and Abilify and Vaniqa (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Abilify and Vaniqa.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Maraviroc and Malaise - 21 seconds ago
- Risperidone and Disopyramide Phosphate drug interaction - 23 seconds ago
- Megace and Tacrolimus drug interaction - 40 seconds ago
- Asmanex Twisthaler and Lymph Follicular Hypertrophy - 50 seconds ago
- Vitamin B1 and Revlimid drug interaction - a minute ago
- Januvia and Lantus Solostar drug interaction - a minute ago
- Lotrel and Meniscus Lesion - a minute ago
- Victoza and Tranexamic Acid drug interaction - a minute ago
- Motrin and Indigestion - a minute ago
- Remodulin and Actemra drug interaction - 2 minutes ago